Rodgers Brothers Inc. Abb Vie Inc. Transaction History

Rodgers Brothers Inc.

  • $725 Million
  • Q3 2024

A detailed history of Rodgers Brothers Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Rodgers Brothers Inc. holds 133,224 shares of ABBV stock, worth $24.4 Million. This represents 3.63% of its overall portfolio holdings.

Number of Shares
133,224
Previous 133,585 0.27%
Holding current value
$24.4 Million
Previous $22.9 Million 14.83%
% of portfolio
3.63%
Previous 3.32%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$163.84 - $199.33 $59,146 - $71,958
-361 Reduced 0.27%
133,224 $26.3 Million
Q2 2024

Aug 14, 2024
SELL
$154.79 - $180.76 $89,468 - $104,479
-578 Reduced 0.43%
133,585 $22.9 Million
Q1 2024

May 14, 2024
BUY
$159.82 - $182.1 $769,693 - $876,993
4,816 Added 3.72%
134,163 $24.4 Million
Q4 2023

Feb 13, 2024
SELL
$137.6 - $154.97 $670,800 - $755,478
-4,875 Reduced 3.63%
129,347 $20 Million
Q3 2023

Nov 13, 2023
BUY
$133.59 - $154.65 $704,687 - $815,778
5,275 Added 4.09%
134,222 $20 Million
Q2 2023

Aug 14, 2023
BUY
$132.51 - $164.9 $773,725 - $962,851
5,839 Added 4.74%
128,947 $17.4 Million
Q1 2023

May 15, 2023
BUY
$144.61 - $166.54 $131,016 - $150,885
906 Added 0.74%
123,108 $19.6 Million
Q4 2022

Feb 14, 2023
SELL
$138.31 - $165.87 $40,524 - $48,599
-293 Reduced 0.24%
122,202 $19.8 Million
Q3 2022

Nov 14, 2022
SELL
$134.21 - $153.93 $65,360 - $74,963
-487 Reduced 0.4%
122,495 $16.4 Million
Q2 2022

Aug 15, 2022
SELL
$137.62 - $174.96 $79,406 - $100,951
-577 Reduced 0.47%
122,982 $18.8 Million
Q1 2022

May 16, 2022
SELL
$131.98 - $163.75 $140,822 - $174,721
-1,067 Reduced 0.86%
123,559 $20 Million
Q4 2021

Feb 14, 2022
SELL
$107.43 - $135.93 $2,685 - $3,398
-25 Reduced 0.02%
124,626 $16.9 Million
Q3 2021

Nov 15, 2021
SELL
$106.4 - $120.78 $1.34 Million - $1.52 Million
-12,615 Reduced 9.19%
124,651 $13.4 Million
Q2 2021

Aug 16, 2021
SELL
$105.21 - $117.21 $116,467 - $129,751
-1,107 Reduced 0.8%
137,266 $15.5 Million
Q1 2021

May 17, 2021
BUY
$102.3 - $112.62 $289,509 - $318,714
2,830 Added 2.09%
138,373 $15 Million
Q4 2020

Feb 16, 2021
BUY
$80.49 - $108.67 $406,957 - $549,435
5,056 Added 3.87%
135,543 $14.5 Million
Q3 2020

Nov 13, 2020
SELL
$85.91 - $100.83 $12,628 - $14,822
-147 Reduced 0.11%
130,487 $11.4 Million
Q2 2020

Aug 13, 2020
SELL
$73.37 - $98.18 $86,063 - $115,165
-1,173 Reduced 0.89%
130,634 $12.8 Million
Q1 2020

May 14, 2020
BUY
$64.5 - $97.79 $86,559 - $131,234
1,342 Added 1.03%
131,807 $10 Million
Q4 2019

Feb 13, 2020
SELL
$72.13 - $90.25 $107,906 - $135,014
-1,496 Reduced 1.13%
130,465 $11.6 Million
Q3 2019

Nov 14, 2019
BUY
$62.98 - $75.72 $134,021 - $161,132
2,128 Added 1.64%
131,961 $9.99 Million
Q2 2019

Aug 14, 2019
BUY
$65.7 - $83.98 $1.09 Million - $1.39 Million
16,578 Added 14.64%
129,833 $9.44 Million
Q1 2019

May 15, 2019
BUY
$77.14 - $90.79 $664,098 - $781,611
8,609 Added 8.23%
113,255 $9.13 Million
Q4 2018

Feb 14, 2019
SELL
$77.85 - $96.01 $116,697 - $143,918
-1,499 Reduced 1.41%
104,646 $9.65 Million
Q3 2018

Nov 14, 2018
SELL
$88.91 - $98.84 $49,078 - $54,559
-552 Reduced 0.52%
106,145 $10 Million
Q2 2018

Aug 14, 2018
BUY
$89.78 - $106.23 $572,257 - $677,110
6,374 Added 6.35%
106,697 $9.89 Million
Q1 2018

May 15, 2018
SELL
$92.01 - $123.21 $36,159 - $48,421
-393 Reduced 0.39%
100,323 $9.5 Million
Q4 2017

Feb 14, 2018
SELL
$89.56 - $98.21 $64,572 - $70,809
-721 Reduced 0.71%
100,716 $9.74 Million
Q3 2017

Nov 08, 2017
BUY
$69.85 - $89.22 $7.09 Million - $9.05 Million
101,437
101,437 $9.01 Million

Others Institutions Holding ABBV

# of Institutions
3,849
Shares Held
1.25B
Call Options Held
16.8M
Put Options Held
12.2M
View Full List

About AbbVie Inc.

ABBV Quotes by TradingView
  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $324B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Rodgers Brothers Inc. Portfolio

Follow Rodgers Brothers Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rodgers Brothers Inc., based on Form 13F filings with the SEC.

News

Stay updated on Rodgers Brothers Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email